Morgan Stanley’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,705
| Closed | -$87K | – | 8115 |
|
|
2022
Q2 | $87K | Buy |
6,705
+200
| +3% | +$2.56K | ﹤0.01% | 6353 |
|
|
2022
Q1 | $101K | Sell |
6,505
-3,178
| -33% | -$53.7K | ﹤0.01% | 6308 |
|
|
2021
Q4 | $206K | Buy |
9,683
+3,130
| +48% | +$79.6K | ﹤0.01% | 6051 |
|
|
2021
Q3 | $193K | Buy |
6,553
+463
| +8% | +$13.9K | ﹤0.01% | 6023 |
|
|
2021
Q2 | $179K | Sell |
6,090
-589
| -9% | -$18.4K | ﹤0.01% | 6071 |
|
|
2021
Q1 | $214K | Sell |
6,679
-1,577
| -19% | -$53.1K | ﹤0.01% | 5629 |
|
|
2020
Q4 | $297K | Sell |
8,256
-104
| -1% | -$3.91K | ﹤0.01% | 5379 |
|
|
2020
Q3 | $321K | Buy |
8,360
+357
| +4% | +$12.9K | ﹤0.01% | 4866 |
|
|
2020
Q2 | $280K | Sell |
8,003
-6,269
| -44% | -$223K | ﹤0.01% | 4910 |
|
|
2020
Q1 | $493K | Buy |
14,272
+631
| +5% | +$22K | ﹤0.01% | 4378 |
|
|
2019
Q4 | $453K | Buy |
13,641
+5,104
| +60% | +$153K | ﹤0.01% | 4982 |
|
|
2019
Q3 | $216K | Buy |
8,537
+1,788
| +26% | +$40.4K | ﹤0.01% | 5088 |
|
|
2019
Q2 | $145K | Sell |
6,749
-404
| -6% | -$8.16K | ﹤0.01% | 5166 |
|
|
2019
Q1 | $122K | Sell |
7,153
-1,078
| -13% | -$16.2K | ﹤0.01% | 5311 |
|
|
2018
Q4 | $96K | Sell |
8,231
-1,169
| -12% | -$15.3K | ﹤0.01% | 5575 |
|
|
2018
Q3 | $155K | Buy |
9,400
+6,368
| +210% | +$96.2K | ﹤0.01% | 5550 |
|
|
2018
Q2 | $38K | Buy |
3,032
+735
| +32% | +$11.2K | ﹤0.01% | 5988 |
|
|
2018
Q1 | $35K | Buy |
2,297
+483
| +27% | +$7.5K | ﹤0.01% | 5985 |
|
|
2017
Q4 | $24K | Sell |
1,814
-1,232
| -40% | -$19.4K | ﹤0.01% | 6031 |
|
|
2017
Q3 | $59K | Buy |
+3,046
| New | +$57.4K | ﹤0.01% | 5737 |
|